Enzolytics Stock

Enzolytics P/B

The P/B (Price-to-Book Ratio) of Enzolytics (ENZC) as of Aug 13, 2026 is -2.67.

P/B

-2.67

Last updated:

P/B (Price-to-Book Ratio) of Enzolytics is 2026 -2.67 . P/B (Price-to-Book Ratio) of Enzolytics was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Enzolytics Stock analysis

What does Enzolytics do? Enzolytics Inc is an innovative biotechnology company specializing in the development of effective therapies for combating infectious diseases and cancer. Enzolytics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzolytics stock

P/B (Price-to-Book Ratio) of Enzolytics is -2.67 in 2026.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Enzolytics since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Enzolytics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Enzolytics

All Key Metrics — Enzolytics